Access notes: Canada
Regulator, prescription status, reimbursement position and practical access route for Canada. Every claim dated, because this changes constantly.
Scope and expiry
Practical access notes for Canada: who regulates, what prescription status applies, how reimbursement is decided, and what route people actually use.
Regulatory and prescription position
Health Canada licenses products; prescribing is provincial. Products in this class are prescription-only.
Coverage and cost
Public drug plans and private insurance differ substantially in what they cover, and coverage for weight management is less common than for diabetes. Provincial formularies are published and are the correct source to check.
Cross-border purchase from the United States is a recurring question and the answer involves both countries' rules. It is more complicated than most summaries suggest.
The route people actually use
In practice the access question in Canada resolves into three sub-questions: whether a prescription can be obtained, whether it will be funded, and whether the product is currently in supply. Those have different answers and different remedies, and conflating them is the commonest reason a member gets stuck.
If funding is the obstacle, the appeal discussion in Access is more useful than another consultation. If supply is the obstacle, the national shortage register — where one exists — is the only source worth reading.
What this page will not help with
This page does not describe how to obtain unlicensed material, and this community does not assist with that. It also does not tell you whether something is legal for you to possess, because that depends on facts about you that a documentation page cannot know.
Research-use-only material is not a licensed medicine in Canada or anywhere else we are aware of.
Contributing
Regional pages are maintained by members in the region. If you can confirm or contradict anything here from a primary source, post in the regional category with the source and the date. An undated claim in this area is worse than no claim, and we will ask for the date.
Revision history
| 2025-08-24 | outline_first | Removed a paragraph that duplicated a linked page, and linked it instead. |
| 2025-04-21 | mira.patel | Added the limitations paragraph. The page previously implied more certainty than the sources carry. |
| 2025-01-14 | q.zhao_qa | Updated a dated claim and added the date explicitly, per the maintenance convention. |
| 2024-11-07 | aliquot_line | Initial promotion from the source topic. Structure taken from the marked solution. |
Every edit to a maintained document records its author and a note explaining the change. An edit without a note may be reverted by any wiki editor under R9, and the revert is logged. Disagreements about content belong on the source topic rather than in the revision history (R10).
Related documents
- Access notes: United StatesRegulator, prescription status, reimbursement position and practical access route for United States. Every claim…